C-reactive protein and 5-year survival in type 2 diabetes: The casale monferrato study

Diabetes

Volumn 58, Issue 4, 2009, Pages 926-933

  Bruno, Graziella ^a   Fornengo, Paolo ^a   Novelli, Giulia ^a   Panero, Francesco ^a   Perotto, Massimo ^a   Segre, Olivia ^a   Zucco, Chiara ^a   Deambrogio, Piercarlo ^b   Bargero, Giuseppe ^b   Perin, Paolo Cavallo ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b Ospedale S Spirito Casale Monferrato   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN;

AGED; ALBUMINURIA; ARTICLE; ASSOCIATION; CARDIOVASCULAR DISEASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROTEIN FUNCTION; RISK FACTOR; SURVIVAL;

AGED; AGED, 80 AND OVER; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BLOOD PRESSURE; C-REACTIVE PROTEIN; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INFLAMMATION; ITALY; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVORS;

EID: 64649099304     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db08-0900     Document Type: Article

References (28)

1. Hansson GK: Inflammation, atheroclerosis and coronary artery disease. NEngl J Med 352:1685-1695, 2005
2. Pai JK, Pischon T, Ma J, Manson JE, Hankinson SE, Joshipura K, Curhan GC, Rifai N, Cannuscio CC, Stampfer MJ, Rimm EB: Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med 351:2599-2610, 2004
3. Ridker PM, Wilson PW, Grundy SM: Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? Circulation 109:2818-2825, 2004
4. Schulze MB, Rimm EB, Li T, Rifai N, Stampfer MJ, Hu FB: C-reactive protein and incident cardiovascular events among men with diabetes. Diabetes Care 27:889 - 894, 2004
5. Pasceri V, Willersone JT, Yeh ET: Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 102:2165-2168, 2000
6. Verma S, Wang CH, Li SH, Dumont AS, Fedak PW, Badiwala MV, Dhillon B, Weisel RD, Li RK, Mickle DA, Stewart DJ: A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation 106:913-919, 2002
7. Aronson D, Bartha P, Zinder O, Kerner A, Shitman E, Markiewicz W, Brook GJ, Levy Y: Association between fasting glucose and C-reactive protein in middle-aged subjects. Diabet Med 21:39 -44, 2004
8. de Rekeneire N, Peila R, Ding J, Colbert LH, Visser M, Shorr RI, Kritchevsky SB, Kuller LH, Strotmeyer ES, Schwartz AV, Vellas B, Harris TB: Diabetes, hyperglycemia, and inflammation in older individuals: the Health, Aging and Body Composition study. Diabetes Care 29:1902-1908, 2006
9. King DE, Mainous AG 3rd, Buchanan TA, Pearson WS: C-reactive protein and glycemic control in adults with diabetes. Diabetes Care 26:1535-1539, 2003
10. Soinio M, Marniemi J, Laakso M, Lehto S, Ronnemaa T: High-sensitivity C-reactive protein and coronary heart disease mortality in patients with type 2 diabetes: a 7-year follow-up study. Diabetes Care 29:329-333, 2006
11. Friedman AN, Hunsicker LG, Selhub J, Bostom AG, the Collaborative Study Group: C-reactive protein as a predictor of total arteriosclerotic outcomes in type 2 diabetic nephropathy. Kidney Int 68:773-778, 2005
12. Wannamethee SG, Lowe GD, Shaper AG, Rumley A, Lennon L, Whincup PH: Insulin resistance, haemostatic and inflammatory markers and coronary heart disease risk factors in type 2 diabetic men with and without coronary heart disease. Diabetologia 47:1557-1565, 2004
13. Vu JD, Vu JB, Pio JR, Malik S, Franklin SS, Chen RS, Wong ND: Impact of C-reactive protein on the likelihood of peripheral arterial disease in United States adults with the metabolic syndrome, diabetes mellitus, and preexisting cardiovascular disease. Am J Cardiol 96:655-658, 2005
14. Malik S, Wong ND, Franklin S, Pio J, Fairchild C, Chen R: Cardiovascular disease in U.S. patients with metabolic syndrome, diabetes, and elevated C-reactive protein. Diabetes Care 28:690-693, 2005
15. Cook NR, Buring JE, Ridker PM: The effect of including C-reactive protein in cardiovascular risk prediction models for women. Ann Intern Med 145:21-29, 2006
16. Cook NR: Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation 115:928-935, 2007
17. Wilson PWF, Nam B-H, Pencina M, D'Agostino RB, Benjamin EJ, O'Donnell CJ: C-reactive protein and risk of cardiovascular disease in men and women from the Framingham Heart Study. Arch Intern Med 165:2473-2478, 2005
18. Sattar N, Murray HM, McConnachie A, Blauw GJ, Bollen EL, Buckley BM, Cobbe SM, Ford I, GawA, Hyland M, Jukema JW, Kamper AM, Macfarlane PW, Murphy MB, Packard CJ, Perry IJ, Stott DJ, Sweeney BJ, Twomey C, Westendorp RG, Shepherd J, the PROSPER Study Group: C-reactive protein and prediction of coronary heart disease and global vascular events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER). Circulation 115:981-989, 2007
19. Bruno G, Merletti F, Bargero G, Melis D, Masi I, Ianni A, Novelli G, Pagano G, Cavallo-Perin P: Changes over time in the prevalence and quality of care of type 2 diabetes in Italy: the Casale Monferrato Surveys, 1988 and 2000. Nutr Metab Cardiovasc Dis 18:39-45, 2008
20. Bruno G, Merletti F, Biggeri A, Bargero G, Ferrero S, Pagano G, Cavallo- Perin P: Fibrinogen and AER are major independent predictors of 11-year cardiovascular mortality in type 2 diabetes: the Casale Monferrato Study. Diabetologia 48:427-434, 2005
21. Bruno G, Merletti F, Bargero G, Novelli G, Melis D, Soddu A, Perotto M, Pagano G, Cavallo-Perin P: Estimated glomerular filtration rate, albuminuria and mortality in type 2 diabetes: the Casale Monferrato Study. Diabetologia 50:941-948, 2007
22. Lamb EJ, Tomson CR, Roderick PJ, Clinical Sciences Reviews Committee of the Association for Clinical Biochemistry: Estimating kidney function in adults using formulae. Ann Clin Biochem 42:321-345, 2005
23. Diabete Italia, AMD (Associazione Medici Diabetologi), SID (Societa Italiana di Diabetologia): Italian standards for diabetes mellitus 2007: executive summary. Acta Diabetol 45:107-127, 2008
24. Rossi MC, Nicolucci A, Arcangeli A, Cimino A, De Bigontina G, Giorda C, Meloncelli I, Pellegrini F, Valentini U, Vespasiani G, the Associazione Medici Diabetologi Annals Study Group: Baseline quality-of-care data from a quality-improvement program implemented by a network of diabetes outpatient clinics. Diabetes Care 31:2166-2168, 2008
25. Harrell FE Jr: Regression Modeling Strategies. New York, Springer-Verlag, 2001
26. Gronnesby JK, Borgan O: A method for checking regression models in survival analysis based on the risk score. Lifetime Data Anal 2:315-328, 1996
27. Zethelius B, Berglund L, Sundstrom, Ingelsson E, Basu S, Larsson A, Venge P, Arnlov J: Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N Engl J Med 358:2107-2116, 2008
28. Schillinger M, Exner M, Amighi J, Mlekusch W, Sabeti S, Rumpold H, Wagner O, Minar E: Joint effects of C-reactive protein and glycated hemoglobin in predicting future cardiovascular events of patients with advanced atherosclerosis. Circulation 108:2323-2328, 2003